Clinical Trials Browser

Interventional × Urinary Bladder Neoplasms × apatorsen × Clear all

NCT01780545 2022-07-11

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

Phase 2 Completed

200 enrolled 11 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00959868 2012-02-13

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

Phase 1 Unknown

Neuronopathy, Distal Hereditary Motor, Type IIB, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms